NCT03199547View on ClinicalTrials.gov

Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death

PHASE3CompletedINTERVENTIONAL
Enrollment

11,985

Participants

Timeline

Start Date

October 21, 2017

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Neonatal SEPSIS
Interventions
DRUG

Azithromycin

The women will be randomized to receive a single dose of Azithromycin or Placebo

DRUG

Placebo Oral Tablet

The women will be randomized to receive a single dose of Azithromycin or Placebo

Trial Locations (2)

Unknown

Clinical Research Unit of Nanoro, Nanoro

Medical Research Council Unit The Gambia, Banjul

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03199547 - Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death | Biotech Hunter | Biotech Hunter